State Street’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

State Street’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-238,243	Closed	-$10.9M	–	3847
2015 Q1	$10.9M	Buy	238,243 +22,667	+11%	+$678K	﹤0.01%	2171
2014 Q4	$5.17M	Buy	215,576 +10,284	+5%	+$232K	﹤0.01%	2553
2014 Q3	$5.18M	Buy	205,292 +35,984	+21%	+$893K	﹤0.01%	2530
2014 Q2	$4.42M	Buy	169,308 +44,778	+36%	+$1.15M	﹤0.01%	2662
2014 Q1	$3.21M	Buy	124,530 +5,121	+4%	+$139K	﹤0.01%	2820
2013 Q4	$2.41M	Buy	119,409 +19,576	+20%	+$461K	﹤0.01%	2975
2013 Q3	$2.61M	Buy	99,833 +39,699	+66%	+$994K	﹤0.01%	2914
2013 Q2	$1.32M	Buy	+60,134	New	+$1.32M	﹤0.01%	3135

State Street's HPTX Position: Q2 2015 in Review

State Street sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 238,243 shares — an estimated $10.9M sold.

State Street first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $10.9M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

State Street reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
State Street sold 238,243 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $10.9M.
State Street first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
State Street's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $10.9M in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on State Street's 13F filing for Q2 2015, filed 13 Aug 2015.